ATE529117T1 - Medizinische zusammensetzung auf wasserbasis mit azithromycin und herstellungsverfahren dafür - Google Patents

Medizinische zusammensetzung auf wasserbasis mit azithromycin und herstellungsverfahren dafür

Info

Publication number
ATE529117T1
ATE529117T1 AT05765316T AT05765316T ATE529117T1 AT E529117 T1 ATE529117 T1 AT E529117T1 AT 05765316 T AT05765316 T AT 05765316T AT 05765316 T AT05765316 T AT 05765316T AT E529117 T1 ATE529117 T1 AT E529117T1
Authority
AT
Austria
Prior art keywords
azithromycin
water
production method
composition containing
medical composition
Prior art date
Application number
AT05765316T
Other languages
English (en)
Inventor
Hidekazu Suzuki
Kuniko Koichi
Kouhei Yoda
Original Assignee
Wakamoto Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharma Co Ltd filed Critical Wakamoto Pharma Co Ltd
Application granted granted Critical
Publication of ATE529117T1 publication Critical patent/ATE529117T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
AT05765316T 2004-07-02 2005-07-04 Medizinische zusammensetzung auf wasserbasis mit azithromycin und herstellungsverfahren dafür ATE529117T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004196315 2004-07-02
PCT/JP2005/012327 WO2006004085A1 (ja) 2004-07-02 2005-07-04 アジスロマイシン含有水性医薬組成物及びその調製方法

Publications (1)

Publication Number Publication Date
ATE529117T1 true ATE529117T1 (de) 2011-11-15

Family

ID=35782886

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05765316T ATE529117T1 (de) 2004-07-02 2005-07-04 Medizinische zusammensetzung auf wasserbasis mit azithromycin und herstellungsverfahren dafür

Country Status (6)

Country Link
US (1) US8153601B2 (de)
EP (1) EP1782816B1 (de)
JP (1) JP3933683B2 (de)
KR (1) KR101130252B1 (de)
AT (1) ATE529117T1 (de)
WO (1) WO2006004085A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007074904A1 (ja) * 2005-12-28 2007-07-05 Wakamoto Pharmaceutical Co., Ltd. 水性医薬組成物
JP2007238607A (ja) * 2006-02-08 2007-09-20 Kawaken Fine Chem Co Ltd 塩素除去剤
US7795231B2 (en) * 2007-10-04 2010-09-14 Insite Vision Incorporated Concentrated aqueous azalide formulations
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
US8106111B2 (en) * 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
WO2012092375A1 (en) * 2010-12-29 2012-07-05 Inspire Pharmaceuticals, Inc. Method for treating dry eye
JP5913367B2 (ja) 2011-01-05 2016-04-27 ホスピーラ インコーポレイテッド バンコマイシンの噴霧乾燥
WO2013103801A1 (en) * 2012-01-04 2013-07-11 Hospira, Inc. Pharmaceutical spray drying
CN102755287A (zh) * 2012-07-20 2012-10-31 天津药业集团新郑股份有限公司 阿奇霉素口服液及其制备方法
CN104043104B (zh) 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法
US11452732B2 (en) 2015-09-05 2022-09-27 Randal Davis Homogeneous ophthalmic composition
US10130639B1 (en) * 2015-09-05 2018-11-20 Randal Davis Homogeneous ophthalmic composition
JP2020203884A (ja) * 2019-06-13 2020-12-24 千寿製薬株式会社 アジスロマイシンを含む製剤の品質管理
US12521411B2 (en) 2024-05-06 2026-01-13 Baxter International Inc. Azithromycin premix formulation and product, methods of preparing same, and methods of using same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
KR100508227B1 (ko) * 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액
JP3147076B2 (ja) * 1997-03-14 2001-03-19 千寿製薬株式会社 ロテプレドノール エタボネート水性懸濁液
ES2221127T5 (es) 1997-12-02 2009-11-10 Pfizer Products Inc. Uso de acitromicina en el tratamiento topico de infecciones oculares.
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
IT1313610B1 (it) 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
US6608033B1 (en) * 1999-08-27 2003-08-19 Pfizer Inc. Treatment or prevention of coccidiosis
JP2001261552A (ja) * 2000-03-22 2001-09-26 Chisso Corp 点眼液用保存剤
HRP20010301A2 (en) 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers

Also Published As

Publication number Publication date
KR101130252B1 (ko) 2012-03-26
US20070087980A1 (en) 2007-04-19
EP1782816B1 (de) 2011-10-19
EP1782816A1 (de) 2007-05-09
JPWO2006004085A1 (ja) 2008-04-10
WO2006004085A1 (ja) 2006-01-12
JP3933683B2 (ja) 2007-06-20
KR20070039040A (ko) 2007-04-11
US8153601B2 (en) 2012-04-10
EP1782816A4 (de) 2008-08-27

Similar Documents

Publication Publication Date Title
NO20085064L (no) 4,5-difenyl-pyrimidinyl-oksy eller -merkaptosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20085066L (no) 4,5-difenyl-pyrimidinyl-aminosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
EP1179341A4 (de) Heilmittel und vorbeugung für mit chemokinen verbundenen erkrankungen
WO2004037811A8 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
WO2002085909A8 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
DE602005023185D1 (de) Prodrugs mit neuen biospaltbaren verbindern
PE20081583A1 (es) Agentes antibacterianos derivados de compuestos carbonilamino
BR0208741A (pt) Derivados de piperidina
BR0111596A (pt) Composto e seu uso, processo para sua produção, composição farmacêutica e processo e método para prevenir ou tratar doenças
IS5632A (is) Amínósýklóhexýletersambönd og notkun þeirra
BR0109703A (pt) Derivados de piperazina
DK1272477T3 (da) Pyrimidinforbindelser
TW333527B (en) Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
PL377838A1 (pl) Zastosowanie pochodnych N-(1-benzylo-2-okso-2-(piperazynylo)etylo)-1-piperydynokarboksyamidowych oraz pokrewnych związków jako antagonistów CGRP do leczenia bólu głowy
ATE221064T1 (de) Cyclische amidderivate als neurokinin a antagonisten
ATE397605T1 (de) Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol
EP1782816A4 (de) Medizinische zusammensetzung auf wasserbasis mit azithromycin und herstellungsverfahren dafür
PL374325A1 (en) Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof
BR0212069A (pt) Agentes antidiabéticos orais
ATE318266T1 (de) 3-substituierte chinolin-4- carbonsäureamidderivate als nk-3- und nk-2- rezeptorantagonisten
DK1026170T3 (da) Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
WO2003066594A3 (de) 3-alkanoylamino-propionsäure-derivate als inhibitoren des integrins avss6
NO20073758L (no) 2-okso-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidiner anvendt som CGRP-antagonister
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties